A summary of the status of the Company’s non-vested stock options (exercisable for shares of Common Stock on a one-to-one basis) as of, and changes during, the nine months ended September 30, 2025 and 2024, is presented below (Details) - $ / shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Share-Based Payment Arrangement [Abstract] | ||
| Nonvested at beginning | 0 | 22,582 |
| Nonvested at beginning | $ 0 | $ 5.74 |
| Granted | 0 | 55,000 |
| Granted | $ 0 | $ 4.40 |
| Vested | 0 | (59,249) |
| Vested | $ 0 | $ 6.15 |
| Expired | 0 | 0 |
| Expired | $ 0 | $ 0 |
| Nonvested at ending | 0 | 18,333 |
| Nonvested at ending | $ 0 | $ 4.40 |
| X | ||||||||||
- Definition The element represents share based compensation arrangement by share based payment award options expirations in period1. No definition available.
|
| X | ||||||||||
- Definition The element represents share based compensation arrangement by share based payment award options grants in period gross1. No definition available.
|
| X | ||||||||||
- Definition The element represents share based compensation arrangement by share based payment award options outstanding number1. No definition available.
|
| X | ||||||||||
- Definition The element represents share based compensation arrangement by shares based payment award options vested and expected to vest outstanding number. No definition available.
|
| X | ||||||||||
- Definition The element represents share based compensation arrangements by share based payment award options exercises in period weighted average exercise price1. No definition available.
|
| X | ||||||||||
- Definition The element represents sharebased compensation arrangement by sharebased payment award options vested weighted average grant date fair value1. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|